Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	81,092	81,092	67,826	78,103	79,498	338,828
Market Cap Growth	-2.03%	19.56%	-13.16%	-1.75%	-76.54%	-27.50%
Enterprise Value	115,356	116,156	86,382	142,444	141,972	399,730
Last Close Price	2170.00	2170.00	1815.00	2090.00	2555.00	13038.48
PE Ratio	-	-	56.63	-	-	-
Forward PE	-	7.87	7.87	7.87	7.87	7.87
PS Ratio	0.97	0.97	1.34	1.38	1.34	5.27
PB Ratio	2.95	2.95	1.10	1.30	0.87	3.43
P/TBV Ratio	3.13	3.13	1.23	1.53	0.95	3.83
EV/Sales Ratio	1.38	1.39	1.70	2.51	2.39	6.22
Debt / Equity Ratio	1.00	1.00	0.66	1.23	0.95	0.75
Net Debt / Equity Ratio	0.61	0.61	0.29	1.09	0.36	0.50
Net Debt / EBITDA Ratio	-1.44	-1.44	-2.51	-3.53	-1.76	-2.23
Net Debt / FCF Ratio	-2.13	-2.13	-0.94	-4.16	-2.15	-1.56
Asset Turnover	0.74	0.74	0.34	0.29	0.27	0.31
Inventory Turnover	7.24	7.24	3.40	4.71	4.72	4.75
Quick Ratio	0.44	0.44	0.53	0.18	0.57	0.66
Current Ratio	0.62	0.62	0.76	0.33	0.73	1.07
Return on Equity (ROE)	-79.17%	-79.17%	5.76%	-42.30%	-44.66%	-35.97%
Return on Assets (ROA)	-10.22%	-10.22%	-6.64%	-8.83%	-7.70%	-9.17%
Return on Invested Capital (ROIC)	-29.24%	-29.60%	-15.56%	-22.02%	-19.80%	-19.54%
Return on Capital Employed (ROCE)	-52.30%	-52.30%	-23.00%	-37.40%	-23.70%	-18.80%
Earnings Yield	-41.43%	-41.43%	1.77%	-40.04%	-52.54%	-11.26%
FCF Yield	-9.61%	-9.61%	-28.13%	-20.16%	-19.47%	-9.42%
Buyback Yield / Dilution	-0.09%	-0.09%	0.35%	-61.23%	-7.58%	-9.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.